Bayer’s Nexavar phase III skin cancer tests fail to meet primary …
Hemscott, UK - Dec 4, 2006LEVERKUSEN, Germany (AFX) – Bayer AG and Onyx Pharmaceuticals Inc said Phase III skin cancer tests of their Nexavar (sorafenib) tablets failed to meet their …
Source: www.hemscott.com

Onyx kidney cancer drug fails skin cancer test
Bizjournals.com, NC - Dec 5, 2006Onyx Pharmaceuticals Inc. and Bayer AG said their kidney cancer drug Nexavar failed in a trial of skin cancer patients. Shares in …
Source: www.bizjournals.com

Green leafy vegetables reduce skin cancer risk
SpiritIndia, India - Dec 4, 2006Skin cancer is a disease in which cancer (malignant) cells are found in the outer layers of skin. The most common types are squamous …
Source: www.spiritindia.com

Green leafy vegetable could reduce skin cancer risk
PakTribune.com, Pakistan - Dec 4, 2006ISLAMABAD: Green leafy vegetable may be as important as wearing a hat, sunscreen and protective clothing to reduce the risk of skin cancer, says a study that …
Source: paktribune.com

Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III
Seeking Alpha, NY - Dec 5, 2006… the company announced at a teleconference that a phase III clinical trial evaluating its cancer drug Nexavar failed to treat advanced skin cancer in patients …
Source: healthcare.seekingalpha.com

Medarex gets ipilimumab FDA fast track
BusinessWeek - Dec 7, 2006said Thursday it received fast track designation from the Food and Drug Administration for its drug to treat two types of skin cancer patients. …
Source: www.businessweek.com